Close

TCR² Highlights Gavo-cel Translational Data and Emerging Solid Tumor Pipeline Preclinical Data at AACR Annual Meeting

Go back to TCR² Highlights Gavo-cel Translational Data and Emerging Solid Tumor Pipeline Preclinical Data at AACR Annual Meeting
(NASDAQ: TCRR) Delayed: 1.48 --0 (-0%)
Previous Close $1.48    52 Week High
Open $1.48    52 Week Low
Day High $1.48    P/E N/A 
Day Low $1.48    EPS
Volume 29,557